8-K: Weave Communications Reports Strong Q2 2025 Growth, Achieves Non-GAAP Profitability

Weave Communications, Inc. announced robust second quarter 2025 financial results, including 15.6% revenue growth and a shift to non-GAAP profitability, alongside the strategic acquisition of AI-powered TrueLark.

Summary

• Total revenue for Q2 2025 reached $58.5 million, marking a 15.6% increase year-over-year from $50.6 million in Q2 2024.
• GAAP gross margin improved to 71.7% (up 30 basis points) and non-GAAP gross margin increased to 72.3% (up 40 basis points) compared to Q2 2024.
• The company achieved non-GAAP income from operations of $0.1 million, a significant improvement from a non-GAAP loss of $1.0 million in Q2 2024.
• Non-GAAP net income was $1.5 million, or $0.02 per share, compared to a non-GAAP net loss of $0.3 million, or $0.00 per share, in Q2 2024.
• Adjusted EBITDA reached $1.1 million, up from a breakeven Adjusted EBITDA in Q2 2024.
• Net cash provided by operating activities year-to-date was $5.2 million, an increase from $3.0 million for the same period last year.
• Free cash flow year-to-date improved significantly to $3.4 million from $0.7 million in the prior year period.
• Gross revenue retention decreased to 90% from 92% in Q2 2024, and net revenue retention declined to 96% from 97% in Q2 2024.
• Weave completed the acquisition of TrueLark, an AI-powered workflow automation platform, to enhance its AI-driven patient engagement offerings.
• Specialty Medical has become the second-largest and fastest-growing vertical by customer count, boosted by new electronic medical record integrations.
• New authorized integrations were launched with Ortho2 Edge (orthodontic) and IDEXX Neo (veterinary clinics).
• Abhi Sharma was promoted to Chief Technology Officer.
• The company provided Q3 2025 revenue guidance of $60.1 $61.1 million and full-year 2025 revenue guidance of $236.8 $239.8 million.
• Full-year 2025 non-GAAP income from operations is projected to be between $1.2 million and $3.2 million.

Sentiment

Score: 8

Explanation: The filing indicates strong operational performance with significant improvements in non-GAAP profitability and cash flow, coupled with strategic growth initiatives like the TrueLark acquisition and expansion in key verticals. While GAAP losses slightly widened and retention rates saw a minor dip, the overall trajectory towards operational profitability and strategic market expansion is highly positive.

Positives

• Total revenue increased by 15.6% year-over-year to $58.5 million, demonstrating strong top-line growth.
• GAAP gross margin improved to 71.7% and non-GAAP gross margin to 72.3%, indicating enhanced operational efficiency.
• Achieved non-GAAP income from operations of $0.1 million, a significant turnaround from a $1.0 million loss in the prior year.
• Reported non-GAAP net income of $1.5 million, a positive shift from a $0.3 million loss in Q2 2024.
• Adjusted EBITDA improved to $1.1 million from breakeven in the same period last year.
• Net cash provided by operating activities year-to-date increased to $5.2 million from $3.0 million, showing improved cash generation.
• Free cash flow year-to-date significantly increased to $3.4 million from $0.7 million, reflecting strong liquidity.
• The acquisition of TrueLark is expected to accelerate AI-driven front office automation and enhance customer offerings.
• The Specialty Medical vertical has become the second-largest and fastest-growing by customer count, driven by successful integrations.
• New integrations with Ortho2 Edge and IDEXX Neo expand market reach to thousands of new locations.
• Promotion of Abhi Sharma to CTO signals a focus on continued AI-powered innovation.
• Ranked #1 in 34 categories in G2's Summer 2025 report, reflecting high customer satisfaction.

Negatives

• GAAP loss from operations widened to $10.2 million from $9.3 million in Q2 2024.
• GAAP net loss slightly increased to $8.7 million from $8.6 million in Q2 2024.
• Gross revenue retention decreased to 90% from 92% in Q2 2024.
• Net revenue retention decreased to 96% from 97% in Q2 2024.

Risks

• Potential impact on the businesses of TrueLark and Weave due to uncertainties related to the acquisition.
• Challenges in retaining employees of TrueLark and Weave's ability to successfully integrate TrueLark and achieve expected benefits from the acquisition.
• Ability to attract new customers, retain existing customers, and increase customer use of the platform.
• Ability to effectively manage growth.
• Impact of unfavorable economic conditions and macroeconomic uncertainties on the company's operations.
• Ability to maintain and enhance the brand and increase market awareness of the company, platform, and products.
• Customer adoption rates of the platform, products, and enhancements.
• Fluctuations in customer acquisition costs and effectiveness of sales and marketing strategies.
• Uncertainty regarding the ability to achieve profitability in any future period.
• Competitive pressures within the market.
• Ability to continuously enhance the platform and products to meet evolving customer needs.
• Potential for interruptions in service that could impact customer satisfaction and retention.

Future Outlook

The company expects third quarter 2025 total revenue to be between $60.1 million and $61.1 million, with non-GAAP income from operations ranging from $0.0 million to $1.0 million. For the full year ending December 31, 2025, total revenue is projected to be between $236.8 million and $239.8 million, and non-GAAP income from operations is anticipated to be between $1.2 million and $3.2 million.

Management Comments

• CEO Brett White stated, "Q2 marked another strong quarter for Weave, with solid revenue growth, improved gross margins, and increased free cash flow."
• Brett White highlighted, "We are seeing clear momentum across our growth vectors. Specialty Medical has grown to be our second-largest vertical in location count, mid-market traction continues to accelerate, and we launched additional key integrations expanding our reach to thousands of new locations."
• Regarding the acquisition, Brett White commented, "We also closed our acquisition of TrueLark, which delivers AI-powered workflow automation through 24x7 patient engagement. We're excited to integrate TrueLark into our business, where we see a strong opportunity to enhance our offering and deliver even greater value to our customers."

Industry Context

Weave operates in the small and medium-sized healthcare business sector, providing an all-in-one customer experience and payments software platform. The acquisition of TrueLark aligns with the broader industry trend towards AI-powered automation and enhanced patient engagement solutions, particularly for appointment-based businesses. The growth in the Specialty Medical vertical and new integrations reflect the ongoing digital transformation within healthcare practices seeking to streamline operations and improve patient communication.

Comparison to Industry Standards

• The filing highlights Weave's strong customer satisfaction by noting its #1 ranking in 34 categories in G2's Summer 2025 report and maintaining the top rating in the Patient Relationship Management grid. While specific comparable companies or their numerical results are not provided, these G2 rankings suggest strong competitive positioning within the patient relationship management software market.

Management Changes

Stakeholder Impact

• Shareholders: Positive impact due to improved non-GAAP profitability, strong revenue growth, and increased free cash flow, indicating better financial health and future potential.
• Customers: Enhanced product offerings through the TrueLark acquisition and new integrations, aiming to improve patient engagement and practice efficiency.
• Employees: Promotion of a key executive (Abhi Sharma) signals career growth opportunities, though employee retention from the acquired TrueLark business is noted as a risk.
• Management: Positive performance metrics validate current strategic direction and operational execution.

Next Steps

• Integration and joint go-to-market initiatives for the TrueLark acquisition are underway.
• The company will host a conference call and webcast for analysts and investors on July 31, 2025, to discuss the results.

Key Dates

Recommendation

The company demonstrated strong revenue growth, a significant shift to non-GAAP profitability, and robust free cash flow generation, indicating improving operational efficiency and financial health. The strategic acquisition of TrueLark and expansion into key healthcare verticals position Weave for continued growth and market leadership in AI-powered patient engagement. While GAAP losses persist and retention rates slightly declined, the overall trajectory and strategic moves suggest a positive outlook for long-term investors.

Keywords

Healthcare software, Customer experience platform, Payments software, SMB healthcare, AI automation, Patient engagement, Practice management, SaaS, Financial results, Earnings, Acquisition, TrueLark, WEAV